在日本用于痴呆症评估的神经心理测试:当前状态
Shinichiro Maeshima1, Aiko Osawa1, Koki Kawamura1
1National Center for Geriatrics and Gerontology, Obu, Japan.
Geriatrics & gerontology international
|September 25, 2023
概括
痴呆症专家主要使用查工具进行诊断,尽管他们认识到评估行为症状的重要性. 未来的护理应该包括对痴呆症患者的生活质量和护理负担的评估.
科学领域:
- 老年医学 老年医学
- 神经学 神经学
- 精神病学是一个精神病学.
背景情况:
- 痴呆症评估对于临床实践至关重要.
- 了解痴呆症专家目前使用的评估工具至关重要.
研究的目的:
- 研究痴呆症专家在临床实践中使用的评估工具.
- 探索选择这些工具背后的原因.
- 确定影响痴呆症护理评估实践的因素.
主要方法:
- 一份问卷调查分发给了日本1858名痴呆症专家.
- 数据收集是在2021年9月至10月期间通过邮件和网页表格进行的.
- 在574名参与者中,实现了32.2%的响应率.
主要成果:
- 大多数专家使用神经心理测试来进行病理生理学识别和诊断.
- 痴呆症的行为和心理症状是关键的评估因素.
- 哈塞川痴呆症尺度修订和迷你精神状态检查是常见的查工具;直接评估包括迷你精神状态检查,时钟绘图测试和立方体复制测试.
- 生活质量和护理负担评估很少进行.
结论:
- 神经心理测试经常被用作快速查方法,尽管它们的主要目的是更深入地理解和诊断.
- 在评估护理负担和生活质量方面存在差距,专家认为这很重要.
- 解决这些评估差距对于全面的痴呆症护理至关重要.
更多相关视频
07:18A Behavioral Test Battery for the Repeated Assessment of Motor Skills, Mood, and Cognition in Mice
Published on: March 2, 2019
19.1K
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
12.2K
相关概念视频
Dementia
131
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
131
Alzheimer's Disease: Overview
513
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
513
